CCM
BNGO icon

Coldstream Capital Management’s Bionano Genomics BNGO Stock Holding History

Coldstream Capital Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-138
Closed -$386 – 1416
2025
Q1 		$386 Buy
+138
New +$903 ﹤0.01% 3407

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SSG
Summit Securities Group New York $1.05B AUM 36.17% 1-Year Est. Return

Coldstream Capital Management's BNGO Position: Q2 2025 in Review

Coldstream Capital Management sold out of Bionano Genomics (BNGO) in Q2 2025, closing a stake of 138 shares — an estimated $386 sold.

Coldstream Capital Management first reported a position in BNGO in Q1 2025 and held it in 1 quarter. The position peaked at $386 in Q1 2025. 29 funds tracked by Wall St. Rank hold BNGO as of Q2 2025.

  • Coldstream Capital Management reported no remaining Bionano Genomics position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 138 Bionano Genomics shares in Q2 2025, an estimated $386.
  • Coldstream Capital Management first reported a position in Bionano Genomics in Q1 2025 and held it in 1 quarter.
  • Coldstream Capital Management's Bionano Genomics position peaked at $386 in Q1 2025.
  • 29 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.